Specifically, in mice bearing both highly leaky CT26 and poorly leaky BxPC3 tumors, it was observed that tumor vascular endothelium could be targeted effectively, showing the rapid and efficient early binding to tumor blood vessels [125]. The gene discussed is DDX53; the disease is neoplasm.